The 'Week in Review' Podcast - 25 August

This is a preview of subscriber content

Subscribe now to continue reading.

The 2023 IGR has reinforced the longstanding isolation of Budget investment in health and new therapeutic technologies as 'costs' that must be managed. It has also acknowledged the challenge of forecasting future spending beyond the short term. We discuss how the IGR and its focus on investment in health as a cost will frame the raft of current review processes. …

Subscribe now to continue reading.

The 'Week in Review' Podcast - 25 August

This is a preview of subscriber content

Latest Video

Most Read

Sussan Ley's sometimes contentious but unquestionably consequential health legacy

PBS spending is driven less by explicit fiscal choices and more by the flow of recommendations

Minister confirms PBS listing for new cystic fibrosis therapy and funded access to other medicines

'It’s the first time in over 30 years that a new way of administering adrenaline has been approved in Australia'

New imaging agent shows stronger detection of recurrent prostate cancer in head-to-head trial

New Stories

Taylor confirms Anne Ruston will retain health portfolio in opposition reshuffle

Minister confirms PBS listing for new cystic fibrosis therapy and funded access to other medicines

Director pay rises across ASX healthcare sector, but gender balance remains uneven

Life sciences sector unites to advance women’s leadership at landmark 2026 events

New imaging agent shows stronger detection of recurrent prostate cancer in head-to-head trial

Medibank funding expansion signals momentum for Emyria’s mental health model

IMF pours cold water on fears of US pharmaceutical tariffs as pressures shift to care spending

Sign In

The 'Week in Review' Podcast - 25 August

This is a preview of subscriber content

Latest Video

Most Read

Sussan Ley's sometimes contentious but unquestionably consequential health legacy

PBS spending is driven less by explicit fiscal choices and more by the flow of recommendations

Minister confirms PBS listing for new cystic fibrosis therapy and funded access to other medicines

'It’s the first time in over 30 years that a new way of administering adrenaline has been approved in Australia'

New imaging agent shows stronger detection of recurrent prostate cancer in head-to-head trial

Follow Us

New Stories

Taylor confirms Anne Ruston will retain health portfolio in opposition reshuffle

Minister confirms PBS listing for new cystic fibrosis therapy and funded access to other medicines

Director pay rises across ASX healthcare sector, but gender balance remains uneven

Life sciences sector unites to advance women’s leadership at landmark 2026 events

New imaging agent shows stronger detection of recurrent prostate cancer in head-to-head trial

Medibank funding expansion signals momentum for Emyria’s mental health model

IMF pours cold water on fears of US pharmaceutical tariffs as pressures shift to care spending